Preclinical and clinical pharmacology of antisense oligonucleotides

By Marcusson E.   Yacyshyn B.   Shanahan W.   Dean N.  

Molecular Biotechnology, Vol. 12, Iss. 1, 1999-08 ,pp. : 1-11

Humana Press, Inc

Access to resources Recommend Favorite

Antisense therapy in clinical oncology: Preclinical and clinical experiences

By Tamm Ingo   Wagner Mandy  

Molecular Biotechnology, Vol. 33, Iss. 3, 2006-07 ,pp. : 221-238

Humana Press, Inc

Access to resources Recommend Favorite

eClinical trials: The future is now

By Marks R G  

Journal of Commercial Biotechnology, Vol. 9, Iss. 1, 2002-09 ,pp. : 49-58

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Targeting Metabolic Enzymes in Cancer – Clinical Trials Update

By  

Current Enzyme Inhibition, Vol. 9, Iss. 2, 2013-09 ,pp. : 152-160

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Is the UK NHS a good place to do clinical trials?

By Steiner Jan  

Journal of Commercial Biotechnology, Vol. 11, Iss. 3, 2005-04 ,pp. : 205-207

Palgrave Macmillan Ltd

Access to resources Recommend Favorite